Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,571.20 +0.73%
EUR-USD 1.2517 -0.1227%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 90.86 +0.22%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: Tokyo
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Takeda Pharmaceutical Co Ltd

Add to Portfolio

4502:JP

3,300 JPY 75 2.33%

As of 02:00:00 ET on 05/25/2012.

Balance Sheet for Takeda Pharmaceutical Co Ltd (4502)

  • Total Assets
  • Total Liabilities (M/JPY)
  • Debt to Assets (%)
All Values in Millions JPY (except Per Share) FH2 2012 FH1 2012 FH2 2011 FH1 2011
Period End Date 3/31/2012 9/30/2011 3/31/2011 9/30/2010
Assets
+ Cash & Near Cash Items 214,885.00 248,551.00 217,876.00 221,982.00
+ Short-Term Investments 240,740.00 157,393.00 656,321.00 583,590.00
+ Accounts & Notes Receivable 341,824.00 348,623.00 293,104.00 294,942.00
+ Inventories 195,014.00 241,308.00 137,127.00 135,430.00
+ Other Current Assets 286,533.00 278,624.00 281,824.00 265,119.00
Total Current Assets 1,278,996.00 1,274,499.00 1,586,252.00 1,501,063.00
+ LT Investments & LT Receivables 206,796.00 162,100.00 178,753.00 171,182.00
+ Net Fixed Assets 488,702.00 474,492.00 407,480.00 382,944.00
+ Other Long-Term Assets 1,602,536.00 1,588,192.00 613,917.00 653,480.00
Total Long-Term Assets 2,298,034.00 2,224,784.00 1,200,150.00 1,207,606.00
Total Assets 3,577,030.00 3,499,283.00 2,786,402.00 2,708,669.00
Liabilities & Shareholders' Equity
+ Accounts Payable 101,950.00 89,886.00 83,065.00 75,381.00
+ Short-Term Borrowings 241,411.00 571,335.00 3,595.00 2,992.00
+ Other Short-Term Liabilities 408,370.00 355,980.00 349,936.00 297,079.00
Total Current Liabilities 751,731.00 1,017,201.00 436,596.00 375,452.00
+ Long-Term Borrowings 317,861.00 N/A 16,387.00 N/A
+ Other Long-Term Liabilities 435,572.00 437,030.00 196,763.00 219,732.00
Total Long-Term Liabilities 753,433.00 437,030.00 213,150.00 219,732.00
Total Liabilities 1,505,164.00 1,454,231.00 649,746.00 595,184.00
+ Total Preferred Equity 0.00 0.00 0.00 0.00
+ Minority Interest 59,522.00 57,343.00 44,732.00 44,673.00
+ Share Capital & APIC 113,683.00 113,555.00 113,513.00 113,424.00
+ Retained Earnings & Other Equity 1,898,661.00 1,874,154.00 1,978,411.00 1,955,388.00
Total Equity 2,071,866.00 2,045,052.00 2,136,656.00 2,113,485.00
Total Liabilities & Equity 3,577,030.00 3,499,283.00 2,786,402.00 2,708,669.00
  • Total Assets
  • Total Liabilities (M/JPY)
  • Debt to Assets (%)
All Values in Millions JPY (except Per Share) FY 2012 FY 2011
Period End Date 3/31/2012 3/31/2011
Assets
+ Cash & Near Cash Items 214,885.00 217,876.00
+ Short-Term Investments 240,740.00 656,321.00
+ Accounts & Notes Receivable 341,824.00 293,104.00
+ Inventories 195,014.00 137,127.00
+ Other Current Assets 286,533.00 281,824.00
Total Current Assets 1,278,996.00 1,586,252.00
+ LT Investments & LT Receivables 206,796.00 178,753.00
+ Net Fixed Assets 488,702.00 407,480.00
+ Other Long-Term Assets 1,602,536.00 613,917.00
Total Long-Term Assets 2,298,034.00 1,200,150.00
Total Assets 3,577,030.00 2,786,402.00
Liabilities & Shareholders' Equity
+ Accounts Payable 101,950.00 83,065.00
+ Short-Term Borrowings 241,411.00 3,595.00
+ Other Short-Term Liabilities 408,370.00 349,936.00
Total Current Liabilities 751,731.00 436,596.00
+ Long-Term Borrowings 317,861.00 16,387.00
+ Other Long-Term Liabilities 435,572.00 196,763.00
Total Long-Term Liabilities 753,433.00 213,150.00
Total Liabilities 1,505,164.00 649,746.00
+ Total Preferred Equity 0.00 0.00
+ Minority Interest 59,522.00 44,732.00
+ Share Capital & APIC 113,683.00 113,513.00
+ Retained Earnings & Other Equity 1,898,661.00 1,978,411.00
Total Equity 2,071,866.00 2,136,656.00
Total Liabilities & Equity 3,577,030.00 2,786,402.00

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement